questionText: To ask the Secretary of State for Health and Social Care, what data the Department holds on the proportion of patients with restless legs syndrome alone, compared with patients with restless legs syndrome and attention deficit hyperactivity disorder, autism or bipolar disorder, who develop new impulse control disorders or worsening pre-existing impulse control traits after dopamine agonist exposure; and whether similar data are available for Parkinson’s disease patients with those co-morbidities.
answerText: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...
heading: Drugs: Side Effects